ArticleResearch square2024

Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's disease.

Carlos Cruchaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.